Healthcare Investment Summit 2018
Riding The New Wave Of Opportunity
Ayushman Bharat, the government’s flagship health protection scheme which will be launched in September, can trigger a tectonic shift in India’s healthcare sector.
In a country where 80% of the 1.3 billion population pays for treatment out of their pockets, Ayushman Bharat promises access to quality healthcare as well as financing for over 500 million people. Needless to say, the inclusion of such a large number of people - through assured funding and financing - into the mainstream healthcare sector presents immense opportunities for all stakeholders across the supply chain.
Industry estimates suggest that the new scheme will bring in demand worth more than Rs 50,000 crore a year. Also, a lot of activity will be centered around tier II and tier III cities. Such huge potential for growth naturally makes the sector extremely attractive for investors including private equity and venture capital firms, which incidentally had pumped more than $1.3 billion into pharma & healthcare equipment and services in 2017. This year, the sector has already received investments in excess of $800 million.
Ayushman Bharat is also expected to speed up consolidation among both the hospital as well as diagnostics streams as big players will most likely want to tap the new opportunity in smaller cities - which were not lucrative enough until now – by snapping up smaller hospitals, specialty clinics & nursing homes, diagnostics services providers, medical devices, et al. And this, again, signifies a huge opportunity for both healthcare entrepreneurs as well as investors.
The new scheme comes at a time when patient awareness and healthcare consumerism is on the rise, the government is seeking better control over the quality as well as the pricing of medicines, devices and services, consolidation in the hospitals and diagnostics segments is underway and global healthcare service providers are setting foot into the market.
Add to this the increasing adoption of emerging technologies, such as artificial intelligence, robotics, machine learning and 3D printing at the end of service providers and the onset of mobile health services to make healthcare more efficient and affordable.
It is against this dynamic backdrop that News Corp VCCircle is organising the 10th edition of its annual Healthcare Investment Summit where industry leaders, legacy and new-age entrepreneurs, and leading PE & VC investors will gather to deliberate upon the right strategies to seize the opportunities in the Indian healthcare market.
08:45am - 09:30am
Registration & Networking
09:30am - 09:45am
Opening Address by
Jonathan Wright, Global Managing Director, Dow Jones & Co.
09:45am - 09:55am
Welcome Address: Healthcare India- Making Sense of the Bold New Renaissance
Jaideep Mehta, CEO, News Corp VCCircle
09:55am - 10:10am
Special Address by Presenting Partner
Satish Chander, Partner, True North
10:10am - 10:50am
Panel I: Government's health drive
The Modi government is on an overdrive to make good on its promise to make healthcare accessible to the underprivileged population. Ayushman Bharat, also dubbed as Modicare, is an ambitious programme that will not only make quality healthcare services available to over 500 million citizens, but will bring in as many customers into mainstream healthcare market and expectedly, open up opportunities worth more than Rs 50,000 crore a year. What will be those opportunities and are service providers ready to top them? What can investors expect?
Harish Pillai, CEO, Aster Hospitals & Clinics, India
Sumit Nadgir, Director, True North
Nitish Agrawal, Managing Director, Indium Capital
Vishal Beri, CEO, Hinduja Healthcare
Archna Shukla, Editor in Chief, News Corp VCCircle (Moderator)
10:50am - 11:10am
Fireside Chat: Consolidation in hospitals
The fiercely-fought battle to take over Fortis Healthcare, the Rs 4,000-crore entry of Malaysian healthcare behemoth IHH into India and the government’s newly- announced Ayushman Bharat are all likely to push consolidation in the hospitals segment and this warrants a detailed look at the possible scenarios.
GSK Velu, Chairman & Managing Director, Trivitron Healthcare
Vishal Bali, Executive Chairman, Asia Healthcare Holdings(Interviewer)
11:10am - 11:25am
Networking Break
11:25am - 12:05pm
Panel II: Capital’s healing touch
For healthcare companies, private equity & venture capital investors have been a big force in driving expansion, consolidation and exploration of newer frontiers. Last year, more than $1.3 billion flowed into the sector way of PE/VC capital. Which new segments, geographies and opportunities are they chasing at the moment?
Amit Varma, Managing Partner, Quadria Capital
Mayur Sirdesai, Partner, Somerset Indus Capital Partners
Praneet Singh, Partner, True North
Rajnesh Trivedi, President, Investment Banking, & Head of Sustainable Investment Banking (SIB), YES SECURITIES
Ranjani R, Associate Editor, News Corp VCCircle(Moderator)
12:05pm – 12:25pm
Fireside Chat: New dimensions in diagnostics
While there has been some action in the diagnostics sector in the recent past, scaling up businesses is something that investors are still wary of. What are the opportunities and the challenges ahead for diagnostics?
A Velumani, Promoter, CMD & CEO, Thyrocare
Anu Acharya, CEO, Mapmygenome
Puncham Mukim, Managing Director, Everstone Capital Advisors (Interviewer)
12:25 pm - 12:40pm
Special Address: Taking treatment to the patients
Yateesh Wahaal, Executive Director, Nayati Healthcare & Research Pvt. Ltd.
12:40pm - 01:20pm
Panel III: Single Specialty hospitals
New age single specialty themes - mother and child care, oncology care, home healthcare -- have attracted significant funding this year. When are they going to break out?
Rohit MA, Cofounder & Managing Director, Cloudnine Group of Hospitals
Kaustav Ganguli, Managing Director, Alvarez & Marsal
Srini Vudayagiri, Investment Director, Peepul Capital
Kiran Gadela, Co founder & Managing Director, Oasis Centre For Reproductive Medicine
Joseph Rai, Principal Correspondent, News Corp VCCircle (Moderator)
01:20pm - 02:05pm
Lunch Break & Networking
02:05pm – 02:25pm
Fireside Chat: King of generics
Will the Indian pharma industry continue to be king of generic drugs? What is withholding investments in R&D? In which direction is the country’s pharma industry moving?
Umang Vohra, Managing Director & Global Chief Executive , Cipla (Interviewee)
Raghav Ramdev, Director, ChrysCapital (Interviewer)
02:25pm - 02:40pm
Report Release - ‘Winning in the IPM: Investment Themes and Alternate Channels of Play’
Jasdeep Singh, Senior Principal and Consulting Head, South Asia, IQVIA
02:40pm - 03:20pm
Panel IV: Digital Healthcare
From online appointments to prescriptions, e-pharmacies to tele-consultation & in-home healthcare to cloud-based health data systems, digital healthcare is plugging gaps in the rural market and delivering convenience to urban customers. How is digital healthcare evolving in India and what is the market opportunity?
Meena Ganesh, CEO & MD, Portea Medical
Ashish Gupta, CEO, DocPrime
Shyatto Raha, Founder & CEO, MyHealthcare
Tushar Kumar, CEO, Medlife
Amit Mookim, Managing Director, South Asia, IQVIA (Moderator)
03:20 pm - 03:40 pm
Fireside Chat: Digital Transformation & Analytics in Indian Healthcare Organizations
Rizwan Koita, CEO, CitiusTech(Interviewee)
Shalil Gupta, Chief Business Officer, News Corp VCCircle (Interviewer)
03:40pm - 04:10pm
Showcase Session
We bring our Showcase session, a curated platform that brings a set of handpicked innovative healthcare startups to make an elevator pitch to select jury of angel investors, houseful of VCs & fellow entrepreneurs. This is also an opportunity to early stage, pre-revenue, startups as well to grab investor attention.
Jury Members:
Ramesh Byrapaneni, Managing Director, Endiya Partners
Mayur Sirdesai, Partner, Somerset Indus Capital Partners
Vishal Bali, Executive Chairman, Asia Healthcare Holdings
Amit Varma, Managing Partner, Quadria Capital
04:10pm - 04:20pm
Tea Break & Networking
04:20pm - 04:35pm
Special address: How is technology changing the paradigm in pharma supply chain
Siddharth Shah, Co Founder & Managing Director, Ascent Health
04:35pm - 05:10pm
Panel V: Tech in Healthcare
Artificial intelligence, Machine Learning, Robotics, Big Data and Analytics are increasingly being used to address complicated health issues as well as make patient centric healthcare possible, both in the Out Patient and In-Patient Settings. A look at the transformation Big Tech is bringing about in healthcare.
Sheriff Sahadulla, Chief Executive Officer & Chief Medical Officer, KIMS Healthcare Group
Sandeep Singh, Healthcare Principal, Eight Roads
Ramesh Byrapaneni, Managing Director, Endiya Partners (Moderator)
05:10pm
End of Conference
Satish joined True North in 2005 and is based in Bengaluru. He joined the firm as part of the business management team and worked with companies across healthcare, media, retail and industrials. He is now part of the investment team and is responsible for investments in healthcare sector.
He holds a Mechanical Engineering degree from the IIT, Chennai and a Post Graduate Diploma in Management from the IIM, Kolkata. Prior to joining True North, Satish had six years of experience working with Tata Motors, Accenture and JP Morgan in India.
Umang Vohra has been Managing Director and Global Chief Executive Officer (MD & GCEO) of Cipla since September 2016. Umang joined Cipla in October 2015 as its Global Chief Financial Officer, and from January 2016 to August 2016 was Cipla’s Global Chief Operating Officer.
After gaining degrees in engineering, marketing and finance, Umang was associated with companies such as Eicher Motors and PepsiCo. Prior to joining Cipla, Umang was Head of the North America business for Dr. Reddy’s Laboratories. Through his previous roles in India and the USA, he has built a distinguished career spanning almost two decades with deep understanding and experience in various aspects of the global pharmaceutical business.
Under Umang’s leadership, Cipla has built strong momentum in its home markets, augmented its capability, strengthened its core, and shown significant improvement in its operating margin and profitability. At the helm of the Management Council of Cipla, Umang’s big-picture agenda is to define and execute Cipla’s strategic growth roadmap and geographical footprint, identify the next levers of growth, invest in innovation for the future, and build the right organisation. Recognised as an action-oriented industry leader, Umang is a firm believer in the power of agile business models, disruptive technologies, data-driven analytics and a future-ready workforce with a view to shaping the healthcare ecosystem and making a difference to the lives of patients.
Over 25 years of Private Equity, strategic & operational leadership and board level experience in healthcare organizations across USA, Asia and Australia.
Co-founder and Managing Partner of Quadria Capital, one of Asia's largest healthcare private equity firms, with assets under management exceeding US$1.6 billion and focused on investing in the healthcare sector across South and Southeast Asia.
Dr. Varma is also the sponsor of Healthquad, a healthcare focused Venture Capital firm investing in technology backed companies in India, and spearheaded India Build Out Fund, US$100 Mn Healthcare and Education focused domestic Private Equity Fund.
Co-led the deployment of RHC Principal , a US$ 700 Mn principal pool of capital, across various healthcare sub sectors in Asia.
Renowned Critical Care Medicine Physician and continues to practice as a critical care physician on a part-time basis.
Has over 25 years of Private Equity, strategic & operational leadership experience in healthcare organizations across USA, Asia and Australia.
Previously, he has been associated with Fortis Healthcare, Narayan Hrudayalaya and Manipal Heart Foundation.
Has also served as an adjunct professor at the University of Pittsburgh and the Cleveland Clinic.
Education:
• M.B.B.S., M.D. from the University of Delhi, India
• Super-specialty medicine training from the University of New York and University of Pittsburgh, USA
• Attended MBA courses at the University of Chicago, USA
Amit leads the commercial business for IQVIA across South Asia. Amit’s responsibility is to leverage IQVIA’s global and regional consulting, data and technology assets and people to assist life sciences, medical technology, healthcare and insurance clients. Amit brings with him a deep knowledge and understanding across key areas like new business setup and growth, strategy, M&A and Private Equity.
Prior to IQVIA, Amit was with KPMG India where he was heading the Healthcare vertical. He was one of the youngest Partners in KPMG and helped the firm build and grow the Private Equity Advisory and Strategy business and also the Healthcare Practice for India and across Asia Pacific. Amit worked across 11 countries across India and Asia Pacific as part of this role.
In his career span of 17 years, Amit has set up and led successful teams in Strategy, PE/ M&A Advisory and Healthcare. He has advised Indian and multinational corporations, funding organizations like the World Bank and DFID, Governments, Private Equity and Venture funds and start-ups. He is a part of some of the leading industry bodies such as FICCI, NATHEALTH, and TiE. Amit has also authored a Thought Leadership for the Future of Healthcare forum which was launched by the President of India in 2014.
In his personal capacity, Amit actively promotes the cause of healthcare entrepreneurship in India and is currently mentoring 2 healthcare start-ups to grow and professionalise. As part of his Board role at TiE, a non-profit organization to support entrepreneurship, Amit has created and set up the healthcare start-up community. The role of this community is to mentor new start-ups in Healthcare and provide them access to mentors, industry and funding.
Amit has done his Bachelor in Economics from University of Kolkata and his MBA from FMS, Delhi. Amit believes that fitness and endurance are two key aspects for personality development and is a long distance runner. He has participated in 15 marathon runs in the last 3 years across 3 countries.
A doctor with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity, Kochi in the year 2013. His ability to strategize and manage large-scale healthcare organisations helped Aster Medcity consolidate its place among the top hospitals in the country in a matter of just one year.
Subsequently, Dr. Harish Pillai was promoted as the Cluster Head of Aster DM Healthcare in Kerala and Hyderabad that included 5 hospitals. He was also responsible for commissioning the upcoming green-field projects of the group. In April 2018, Dr. Harish Pillai was promoted as the CEO of Aster India that is currently spread across 5 states and has 13 hospitals with around 4500 beds and 8 clinics.
An expert in hospital administration, quality, brand management, business strategy, product launches and joint ventures, Dr. Harish Pillai has played a significant role in the development of the healthcare industry in India and the Middle East & North Africa (MENA) by setting new benchmarks in quality and patient care.
Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. He has also been instrumental in implementing several high-value healthcare initiatives in Cairo.
One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai is a Member of the Joint Commission International (JCI) Standards Advisory Panel; Member of Governance Council of Association of Healthcare Providers (AHPI); National Co- Chair for Medical Value Travel Committee in Federation of Indian Chambers of Commerce and Industry (FICCI); Elected secretary of the Kerala Medical Value Travel Society (KMVTS); visiting faculty at Tata Institute of Social Sciences (TISS) Mumbai and Administrative Staff College of India (ASCI) Hyderabad.
Dr. Harish Pillai has featured in the April 2018 Cover Story of Healthcare Radius Magazine and was conferred with a Special Jury Award for CEO of The Year at the 1st BW Healthcare Hospital Summit & Awards in May 2019.
A doctor with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity, Kochi in the year 2013. His ability to strategize and manage large-scale healthcare organisations helped Aster Medcity consolidate its place among the top hospitals in the country in a matter of just one year.
Subsequently, Dr. Harish Pillai was promoted as the Cluster Head of Aster DM Healthcare in Kerala and Hyderabad that included 5 hospitals. He was also responsible for commissioning the upcoming green-field projects of the group. In April 2018, Dr. Harish Pillai was promoted as the CEO of Aster India that is currently spread across 5 states and has 13 hospitals with around 4500 beds and 8 clinics.
An expert in hospital administration, quality, brand management, business strategy, product launches and joint ventures, Dr. Harish Pillai has played a significant role in the development of the healthcare industry in India and the Middle East & North Africa (MENA) by setting new benchmarks in quality and patient care.
Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. He has also been instrumental in implementing several high-value healthcare initiatives in Cairo.
One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai is a Member of the Joint Commission International (JCI) Standards Advisory Panel; Member of Governance Council of Association of Healthcare Providers (AHPI); National Co- Chair for Medical Value Travel Committee in Federation of Indian Chambers of Commerce and Industry (FICCI); Elected secretary of the Kerala Medical Value Travel Society (KMVTS); visiting faculty at Tata Institute of Social Sciences (TISS) Mumbai and Administrative Staff College of India (ASCI) Hyderabad.
Dr. Harish Pillai has featured in the April 2018 Cover Story of Healthcare Radius Magazine and was conferred with a Special Jury Award for CEO of The Year at the 1st BW Healthcare Hospital Summit & Awards in May 2019
Dr. Ramesh Byrapaneni is a cardiologist who turned into a venture capitalist, to be a part of the healthcare innovation story.
His current focus on investments in the healthcare world, mainly digital health and medical devices. Prior to Endiya, at Ventureast, he invested in companies like OneBreath which is into mechanical ventilation and SmartRx, an innovator in mobile engagement platforms for healthcare. Dr. Ramesh is also an angel investor with Nephroplus, India’s largest chain of dialysis clinics.
In his early years, Dr. Ramesh was Chief of Cardiology and Founder of Medwin Hospital. He did his post-graduation in Internal Medicine, postdoctoral fellowship in Cardiology from PGI, Chandigarh, and Interventional Cardiology Fellowship from University of Alabama, Birmingham, USA. He was also adjudged the Best Outgoing Student from the University of Alabama.
Entrepreneurship and innovation always spurred Dr. Ramesh, leading him to be the President of TiE Hyderabad for four years. He is also the Founding Director of Hyderabad Angels.
When he is not mentoring, coaching and guiding entrepreneurs, Dr. Ramesh spends his available time in social ventures. He is a Founding Chairperson of the Hyderabad 10k run and a Board Member of United Way Hyderabad.
Meena is one of India’s foremost business leaders and most successful entrepreneurs with nearly three decades of experience in industries including healthcare, consulting, technology, outsourcing, education and e-commerce.As the MD & CEO, Meena heads Portea Medical, India’s largest and fastest growing home healthcare company, which she co-founded in July 2013.
Till February 2013, Meena was a promoter and board member of TutorVista, and CEO and MD of Pearson Education Services.As a partner of the platform, Growthstory.in, she is also co-promoter of nearly a dozen, new-age Internet / Technology enabled start-ups. A few of them that are leaders in their category include Bigbasket.com - India’s premier e-grocery retailer, home solutions company - HomeLane, Food Tech company - FreshMenu, and Bluestone.com – India’s leading online jeweler.
Meena has also co-founded Customer Asset, one of India’s pioneering BPO companies which she sold to ICICI OneSource. She also had a five year stint with Microsoft India‚ during which she set up multiple business units including Microsoft Consulting‚ Internet and Application Development/Business services units. During the initial 11 years of her career, Meena was with PricewaterhouseCoopers and with NIIT.
Meena is a PGDM holder from IIM Calcutta has a graduate degree in Physics from the Madras University.In 2015, Meena was among the 7-member jury for the inaugural Economic Times Startup Awards and in November of the same year, was selected by Fortune India as one of the 50 'Most Powerful Women in Business.'
Meena serves as a member of the CII-Innovation & Entrepreneurship Council.
@meenaganesh
Vishal Bali brings with him 28 years of experience in building and leading global healthcare delivery organizations across developed and developing countries through a combination of organic and M&A driven strategic growth. Vishal brings with him a unique and diversified business experience of managing a $ 1bn P&L of an integrated healthcare delivery organisation comprising a wide spectrum of healthcare verticals including Hospitals, Diagnostics, Primary Care and Daycare Speciality networks across Asia Pacific. Having worked with a highly talented and multi cultural global team based in Singapore, Australia, India, Hong Kong, Vietnam, Srilanka, Dubai and multiple other countries has given him the exceptional opportunity to grow teams and transform healthcare businesses across geographies.
Vishal is currently Executive Chairman, Asia Healthcare Holdings and Senior Advisor, TPG Growth. He is also Co-founder of Medwell Ventures.
Asia Healthcare Holdings is the single speciality healthcare delivery platform backed by TPG Growth which has built India’s second largest Oncology hospitals chain and the largest Mother & Child network in the country. Prior to his current assignment Vishal was the Group CEO for Fortis Healthcare Limited, India’s second largest healthcare delivery enterprise with a network of 68 hospitals and a pan India pathology diagnostics chain. He led Fortis Healthcare’s foray to build Asia's leading integrated healthcare delivery system with a presence across 12 countries and a human capital base of more than 20000 people. One of his key contributions in the Indian healthcare ecosystem includes spearheading the growth and transformation of Wockhardt Hospitals from a single hospital to one of the largest pan India speciality hospital chains as its CEO & Managing Director. He led India’s largest healthcare delivery merger of Wockhardt Hospitals with Fortis Healthcare. Vishal’s expertise in healthcare M&A, post merger integration and divestments has given him a unique perspective on the rapidly evolving healthcare sector of Asia Pacific. He completed his Bachelors in Science and Post graduation in Business from Bombay University and completed an advance program in hospital management from Harvard Medical, Boston. He sits on the board of leading healthcare organisations and has been an invited member of the Strategic Initiatives group of Joint Commission International, US and a past member of the Global Agenda Healthcare Council of the World Economic Forum. His keen interest in education and globalisation of healthcare takes him to leading Healthcare Education Institutes and Business Schools globally which include case studies at the Harvard Business School. He is an active member of various Industry bodies and globally recognized industry public speaker.
As co-founder and Chief Executive Officer, Rizwan Koita drives CitiusTech’s worldwide business strategy, including healthcare technology innovation and healthcare domain expertise development. Under his leadership, CitiusTech has become the largest healthcare technology company in India, with over USD 150MN in revenue, serving more than 110 leading healthcare organizations worldwide. In 2014, General Atlantic invested $110 MN in CitiusTech, valuing it at over Rs. 2,000 Crore.
Before CitiusTech, Mr. Koita was the CEO and founder of TransWorks (now part of Concentrix, the world’s #1 BPO company) one of the first business process outsourcing (BPO) firms in India, with over 21,000 employees worldwide today. Earlier, he was a senior consultant with McKinsey & Co., where he consulted transnational clients on exploiting remote service opportunities.
Mr. Koita is a winner of the 2013 Ernst & Young Entrepreneur of the Year Award. He is also a recipient of the 2002 Indo-American Society's Young Achievers Award in Business. He has a Master’s Degree from the Massachusetts Institute of Technology (MIT) and a Bachelor’s Degree in Engineering from IIT Bombay.
A visionary and an able business administrator, Dr. A. Velumani proves amply clearly to industry that, “Focus gives Success”. Born toa landless farmer in a small village near Coimbatore, South India, today he owns and operates Thyrocare, an industry leader and a brand worth over Rs. 3000 crores. Began as a mathematician, he acquired his Ph.D in Thyroid Biochemistry from BARC / Mumbai University. He worked for 14 years in BARC as a Research Scientist and Teacher and then became an administrator in business.
He is also MD of Nueclear Healthcare Limited which is a Radiology vertical. His focus areas are Thyroid Biochemistry, Bioanalytical Chemistry, Nuclear Chemistry and Nuclear Medicine.
An infectious motivator, he has succeeded in converting educated as employed, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealth creators and by his unique way, transformed intimidating problems into opportunities.
He is hilarious when it comes to educating and motivating youth in Entrepreneurship.
Praneet joined True North in Oct 2017 and is based in the Mumbai office, where he works closely to build and manage True North portfolio companies in the healthcare space. With over 26 years of experience in the emerging markets, Praneet brings expertise in general management, leadership development, marketing, investing and consulting, with a specific focus on the healthcare and consumer industries. He has worked in diverse markets globally - in India, Southeast Asia, Latin America and the US.
Prior to joining True North, he was with Siguler Guff and Company, building and managing their portfolio of private equity investments in India and Southeast Asia. Before that, he spent five years as the CEO of Piramal Healthcare's India pharmaceutical business, growing it more than three-fold during that period. He has also done long stints as a consultant with McKinsey and Company, focusing on operations and marketing strategy, and as a brand manager with Procter & Gamble. He holds an MBA degree from IIM Calcutta and a bachelor's degree in Mechanical Engineering from IIT Delhi.
Mayur has over 25 years of experience in Healthcare/ Pharma and FMCG and has worked in various roles like Private Equity, Strategy, Advisory Services, Operations, Manufacturing and Marketing in this sector. Currently, Mayur runs a Healthcare focused PE fund called Somerset Indus Capital Partners focused on investments in products and services platforms in the SME sector of Healthcare in India.
He has made several investments across Pharma, Nutrition, Medical Technology, Diagnostics and Healthcare Delivery. He has a strong network across the Indian Healthcare sector at the Senior Management Level and in the past, has worked in large professional companies like IMS Health and Colgate Palmolive as well as his family run organization – Kare Group in an entrepreneurial capacity. He has also built start ups in the areas of Medical Devices and Stem Cell Banking and Research.
He has also been involved in the Healthcare start up space wherein he has mentored several healthcare entrepreneurs and is an Investment Committee member of a Healthcare Start up Incubator called Health Start in Delhi. He has also helped in the organisation of a Healthcare conference on Digital Healthcare with the TiE Pune chapter last year.
Mayur attended IIT Bombay between 1983-87 wherein he did his B. Tech in Chemical Engineering followed by a Masters in Chemical Engineering at Pennsylvania State University in 1989 and a MBA at University of Texas at Austin in 1991. Being from a family with a lifelong association with Pharma, Mayur naturally moved into the Pharma/Lifesciences sector which he has been part of in various roles throughout his career.
Indium is a healthcare focused investment banking advisory firm. Based in Bengaluru, Nitish has advised on domestic and cross border M&A as well as equity fund raising transactions across all segments of healthcare including large hospital chains, single speciality formats (maternity, IVF, etc), diagnostics, medical devices, and healthcare-tech with a cumulative experience of evaluating over 45+ deals in healthcare.
Nitish has had over 18 years of leadership experience in the past across Allegro Capital, GE Capital & Genpact. He is an engineer from IIT, BHU and holds a Post Graduate Diploma in Management from IIM Calcutta
Sumit joined True North in 2016 and is based out of Mumbai. He is closely involved in supporting and building True North companies across different sectors including healthcare, consumer goods, industrial services, etc. He is a Mechanical Engineer from Pune and has a Post Graduate Diploma from Indian Institute of Management, Kolkata.
Prior to joining True North, Sumit was a Principal with Bain & Co. where he supported several domestic & multinational firms across sectors including industrial goods & services, textiles, chemicals, infrastructure, health care, consumer goods dealing with growth strategies, operational efficiency, cost reduction, organization effectiveness, etc. Before Bain, he helped set up an engine manufacturing plant for the Kirloskar Group and implement lean systems across their operations. Earlier, he worked with J&J Medical, where he managed the sales of cardiac devices.
Rohit M A is the Cofounder and Managing Director of Cloudnine Group of Hospitals - India’s leading chain of maternity, women and child care service hospitals. Rohit has played a crucial role in the establishment and growth of the company and expanded operations from a single hospital in South Bangalore to other locations in Bangalore and now a multicity-chain across Chennai, Gurgaon, Mumbai, Pune, Navi Mumbai, Chandigarh, Delhi with more than 18 units and in the pursuit to setup 10 more units in the coming years.
As Managing Director, Rohit currently oversees and is actively involved in several core areas of Cloudnine including strategy, digital revolution, public relations, employee engagement and with critical focus on expansion of presence and development of new business models for the company. He has also led and managed the entire gambit of professionalizing the company and attracting top talents who form the core team of Cloudnine and also been responsible for leading the entire journey and stake holder management of private equity investors and has attracted investments of over 100 million dollars through marquee investors, in the likes of Matrix Partners, Sequoia Capital and TrueNorth (previously IVFA) having invested in to the company.
Jasdeep is a Senior Principal located out of IQVIA’s corporate office in Mumbai, and heads the Consulting and Services business for South Asia. He also drives the Private Equity program and cross-border collaboration work.
Jasdeep has been in the healthcare and pharma industry for over 15 years and is a trusted advisor to leading domestic and MNC companies. He is a healthcare consultant with on-ground industry experience across functions of R&D and strategy, across emerging and regulated markets. His core expertise lies in large strategy and growth oriented projects, Pricing and Market Access strategies, market entry and expansion strategies, organization restructuring and commercial due-diligence.
Prior to joining IQVIA, Jasdeep had his stints at Monitor Group and Ranbaxy (EA to CEO). He is part of many industry forums, as speaker, especially forums focusing on Private Equity and Life Sciences.
Jasdeep has done his Ph.D. in Chemical Engineering from Cambridge University, Executive Education Program from London Business School and his Undergrad Degree from IIT Delhi.
Ashish Gupta is the CEO of docprime.com (A Policybazaar Group company) and Chief Technology Officer (CTO) of Policy Bazaar.com. docprime.com is the latest healthcare venture by the Policybazaar Group intending to transform the role digital technologies play in the discovery and delivery of healthcare services.
Ashish joined Policybazaar in 2015 and since then has been responsible for providing seamless customer experience on the website. He has been instrumental in bringing the technological innovations in the company such as India’s first AI-powered chatbot PBee to sell insurance online. He also leads all digital marketing activities in the company and has been instrumental in driving the revenue through market research, product marketing, and content marketing.
Prior to joining Policybazaar, Ashish served as Vice-President and CTO at HealthKart and was also the founder of online coupon-search portal CouponVoodoo.com. He started as a management trainee with the automotive division of ICI Paints and juggled in cross-functional roles. When not working, he loves to unwind himself by traveling, driving or watching TV. Ashish is a graduate in Chemical Engineering from IIT Delhi.
Ms. Anu Acharya is co-founder and CEO of Mapmygenome India, a company that pioneered the field of personalised, preventive healthcare by making personal genomics tools available to the masses. With a vision to “Touch 100 million lives”, Mapmygenome was established in 2013, heralding the advent of improved healthcare through genomics based personalised, precision medicine in India.
Ever since, she has successfully pioneered the company through growing product lines, expanding affiliate network and has received funding from stalwarts like Mr. Ratan Tata and Mr. Rajan Anandan and more. She is a distinguished alumna from IIT Kharagpur. Under her leadership, the company has gone from strength to strength, achieving several milestones, awards and honors. From the ET startup Awards to NASSCOM Emerge 50, WSJ’s Top global startups award, Red Herring Asia and Global to the recently conferred Pride of Telangana award; Mapmygenome has certainly become a force to be reckoned with.
Her entrepreneurial journey began back in 2000, when she founded Ocimum Biosolutions - a global genomics outsourcing partner for discovery, development and diagnostics. With her at the helm as CEO for 13 years, Ocimum flourished through three strategic international acquisitions, two capital raises for equity investments and launch of several innovative products, solutions and services through its proprietary platform called RaaS (Research as a Service). An entrepreneurial success
story that made its way into the Harvard Business Review as a case study.
An author of several research papers published in major journals, various articles for journals like Nature, Ms. Anu Acharya recently received early publication approval for her patent for SNaPpy - the genetic risk prediction algorithm developed in-house at Mapmygenome. A fiercely respected entrepreneur, she also serves as a governing board member for various high profile institutions such as the NIBMG,NIAB, KIIT, IvyCap Ventures, CSIR and ABLE to name a few.
Puncham Mukim, Puncham Mukim joined Everstone in 2011 and works within the investments team, specialising in investments for the health-care and consumer sectors. Prior to joining Everstone in 2011, Puncham had over four years of experience in financial services including three years in private equity investing.
Earlier, Puncham worked with Warburg Pincus and J.P. Morgan in India. He holds a Bachelor of Management Studies degree from the University of Mumbai, and an MBA from Symbiosis Institute of Business Management. As part of the Everstone investment team, Puncham was actively involved with the Global Hospital investment. In his previous role, Puncham was also part of the team which invested in Metropolis Healthcare.
Kaustav Ganguli is a Managing Director with Alvarez & Marsal and leads the healthcare practice for the firm in India and the Middle East. Mr. Ganguli has more than 16 years of experience in consulting and industry across the healthcare and life sciences sectors. Till date, he has advised on more than 60 engagements across the healthcare value chain, spanning hospitals, single specialty models, outreach models, diagnostics, pharmacy, health IT, health education, medical equipment and devices and health insurance.
Over the last decade, Mr. Ganguli has advised large international organizations on their India entry as well as many leading domestic organizations on opportunities related to expansion, diversification and growth. Additionally, he has helped several organizations improve their operational performance and advised several private equity funds on transactions in Indian Healthcare space. Mr. Ganguli earned his engineering degree from Jadavpur University and completed his MBA from SP Jain Institute of Management and Research.
Dr. Sheriff Sahadulla is the Chief Executive Officer and Chief Medical Officer for the KIMS Healthcare Group in the Middle East. Dr. Sahadulla obtained his MD from Tufts University in Boston and did his Post graduate training in Internal Medicine at the University of Michigan. Dr. Sahadulla is American Board Certified in Internal Medicine and is also a Senior Fellow of Hospital Medicine.
Prior to joining KIMS, Dr. Sahadulla was based in Boston and held the position of Regional Medical Director for TEAMHealth, a National Healthcare Management Company. Dr. Sahadulla has also held the position of Medical Director and President of the Medical Staff, St. Joseph Hospital, Nashua.
Dr. Sahadulla has won numerous awards including TOP DOC by New Hampshire Magazine in 2011 and 2014, Regional VP of the year from TEAMHealth and several patient care awards.
Rajnesh Trivedi is President Investment Banking team at YES Securities, a 100% subsidiary of YES BANK. Rajnesh has 18 years of Corporate Finance and Investment Banking experience having worked across sectors. At YES Bank, / YES Securities, Rajnesh has led over 25 successful M&A, PE and ECM transactions in domestic markets as well as cross border. Additionally Rajnesh leads the Sustainable Investment Banking (SIB) division of YES BANK, which focuses on providing Investment Banking & advisory services to businesses operating in the area of renewable energy, environmental services, healthcare, education, social & financial inclusion.
Rajnesh leads some of YES Bank’s key lending relationships in the healthcare sector & has led multiple investment banking transactions including across M&A, Private Equity & Capital Markets.
Shyatto’s experience in business strategy spans the Indian Sub-Continent, South East Asia and the Middle East. He has worked with organisations such as the NDTV Group, Astro Networks (Malaysia and Indonesia). He was responsible for setting up and managing the operations of NDTV’s news network (STAR News, NDTV 24x7, NDTV India and NDTV Profit).
Over the past 3 years, as founder, Shyatto has focussed on building MyHealthcare. MyHealthcare is a digital healthcare ecosystem that enhances patient engagement and empowers them with their healthcare needs, through offerings such as EHR, health trackers, emergency services, video consult, 24x7 health monitoring, etc. The platform helps connect healthcare givers, hospitals, diagnostics, patients and their family and brings them into a digital ecosystem. MyHealthcare has at its core a HIPAA compliant MyHealthcare SPINE that connects with HIS and offers a user-friendly patient app, a doctor app, a paramedic app, a customer website widget and an internal hospital portal (a patient support platform for the hospital team). The platform is offered in a partnership model with hospitals and healthcare institutions.
Shyatto is an alumnus of the Harvard Business School and a member of the Harvard Angels Network (India).
Tushar belongs to the promoter group of India’s leading pharmaceutical company. He comes from a family of Pharma entrepreneurs and was briefly involved in the family-run Alkem Laboratories. He has a rich experience of e-commerce & Pharma business in the global space.
Tushar is an Economics & Statistics graduate. While still in college, he started an international marketing company and with the first venture, itself, he was successful in creating a global footprint. Tushar later joined his family business for the next 3 years and this stint helped him understand better the intricacies of running a business.
Sandeep is a Principal with the Healthcare team at Eight Roads Ventures (India). With over 7 years’ experience in investing, Sandeep specialises in the healthcare sector, particularly in health tech, healthcare services, consumer health and India pharmaceuticals.
Prior to joining Eight Roads, he was with Matrix Partners India where he also looked at consumer goods and services companies.
Before stepping into the venture capital world, Sandeep spent 6 years in consulting having worked with both the Boston Consulting Group and McKinsey & Co. where he specialised in the healthcare and consumer practices.
Sandeep holds a Post Graduate Degree in Management from the Indian Institute of Management, Bangalore where he was recognised for his achievements and was part of the Director’s Merit List. He also holds a Bachelor’s degree in Technology from IIT Kharagpur and was awarded the Institute Silver Medal and the A. C. Sarkar Memorial Gold Medal.
Raghav has been with ChrysCapital since September 2003 and focuses on the healthcare sector, one of the four focus sectors for the Firm. He has been involved in all their 9 investments in the sector made since CY06 of which five have been fully exited at an ROI of over 5.2x. Previously, he was with the global research division at McKinsey & Company. Raghav received an MBA from Management Development Institute, Gurgaon and a Bachelor's degree in chemical engineering from Baroda University.
Dr. Vishal Beri is the Chief Executive Officer of Hinduja Healthcare Surgical (HHS), Mumbai. HHS marks the Hinduja group’s foray into the corporate healthcare sector. In his current role, Dr. Beri is responsible for the overall functioning of this hospital and driving strategic healthcare initiatives for the company.
His vision for HHS is to be the best in class neighborhood hospital providing personalized quality medical care and service with an ‘un-hospital’ like engagement with patients and their families. In his words “HHS will provide up-end personalized care in an environment that is accommodating rather than intimidating”.
A medical doctor, Dr. Beri has done his MBBS from KEM hospital, Mumbai and his post-graduation in Orthopedic Surgery from Nair Hospital. He practiced as a Consultant Orthopedic surgeon to four years before moving on to obtain a Management Degree from the prestigious Indian School of Business (ISB), Hyderabad.
Dr. Beri brings with him over 15 years of rich experience in the healthcare domain, both as a clinician as well as a management professional. Prior to HHS, Dr. Beri was the Chief Operating Officer of BGS Global Hospitals, Bangalore, where he was involved with the HIMS implementation, ramping up of hospital capacity, forging strategic alliances with other smaller hospitals within the city as well as preparing the hospital for accreditation.
When not working, he loves travelling and meeting new people. He is also regularly invited for talks and panel discussions at several prominent healthcare forums.
34 year old Yateesh Wahaal, is a B.Tech in Electronics & Communications and Business Administration (Finance & Marketing). He has also done advance management programme from the NUS, Singapore & ISB Hyderabad and specialized course in Private Equity from ISB Hyderabad.
Yateesh began his professional career more than a decade ago as a Banker with the then Centurion Bank. Defying conventional thinking, Yateesh joined start-up consultancy Noesis, helping clients with important acquisitions and development in New York, India, Oman, United Kingdom, France, Brazil, Russia, and Indonesia across industries like telecom, real estate, iron ore, oil & gas and automobiles, amongst others. Yateesh set-out to establish and head Pegasus, another consulting firm out of Africa, India and South East Asia, incubating companies and guiding them for eventual listing at the bourses.
Currently, Yateesh is the Executive Director of Nayati Healthcare, pursuing its vision of offering quality healthcare to people living in tier II & III cities of India.
Kiran Gadela is a healthcare entrepreneur and is the co-founder ,Managing director of Oasis Centre for Reproductive Medicine, a leading chain of IVF and fertility treatment centres in India. (www.oasisindia.in).
Kiran founded Oasis (a Unit of Sadguru Healthcare Pvt Ltd) in 2009 along with renowned IVF specialist Dr.Durga Rao, and the company currently operates 9 centres in Telangana, AP and Tamil Nadu. The company is headquartered in Hyderabad. Known for its highly specialized and advanced treatments in the field of reproductive medicine, Oasis has been ranked #1 in Hyderabad, #2 in South India and #3 in India by Times of India Survey 2018. It has also been listed as one of the top 1000 fastest growing companies in Asia by the Financial Times.
Oasis is one of the few chains in the field of reproductive medicine in Asia that has raised institutional growth capital in 2016 from India Life Sciences Fund, and is currently executing its expansion plans in India. Prior to starting Oasis, Kiran worked for over 13 years in IT and Financial Services in leading investment banks in London. Kiran holds a degree in civil engineering and is an alumni of INSEAD business school.
True North traces its origins back to 1999, when it was originally named India Value Fund. The company was founded with a view towards investing in mid-sized, profitable, India-centric businesses, and then transforming them into world-class industry leaders that is built upon the foundation of strong values.
Deep knowledge and understanding of Indian markets has led True North to successfully launch five independent investment funds, with a combined corpus of ~US$ 2 billion. These funds have been raised from over 35 high quality international institutions with a combined investable capital base of over US$ 1 trillion. Currently, True North is investing out of Fund V, which has a corpus of US$ 700 million.
Over the last two decades, True North has invested ~US$ 1.5 billion across 30+ businesses. It has successfully transformed many of these companies into large businesses that are valuable, enduring, and socially responsible, creating immense value for all stakeholders.
Our team consists of a balanced mix of investment and business professionals, with deep investing and operating experience.
True North truly values its relationships with investors, entrepreneurs and management teams. It is conscious of its fiduciary duty towards its investors while partnering with entrepreneurs to realize their visions, and with management teams to maximize their career potential.
Nayati is one of India’s fastest growing hospital chains providing comprehensive and world-class healthcare services. Established with the aim of taking treatment closer to people, the group is committed to providing transparent, competitive, accessible and affordable healthcare services at par with international standards to all. In a short span of time, it has grown into a 1200 bed chain and counting with hospitals in strategic locations in North India.
\r\n
MyHealthcare is an integrated digital healthcare ecosystem, a flagship product of InnoCirc Ventures. The platform is designed to work with hospitals in building out and scaling their digital healthcare roadmap. The MyHealthcare ecosystem enhances patient engagement and empowers them with their healthcare needs, through offerings such as mobile EMR, health trackers, emergency services, video consult, 24x7 health monitoring, etc. The platform helps connect healthcare givers, hospitals, diagnostics, patients and their family and brings them into a digital ecosystem. MyHealthcare has at its core a HIPAA compliant MyHealthcare SPINE that connects with HIS and offers a user-friendly patient app, a doctor app, a paramedic app, a customer website widget and an internal hospital portal (a patient support platform for the hospital team). The platform is offered on a partnership model with hospitals, whereby MyHealthcare operates as the technology partner for the hospital network across all their patient facing and care delivery services. The platform operates with a vision to improve patient care using digital technology and AI in delivering quality healthcare services.
\r\n
CitiusTech is a specialist provider of healthcare technology services and solutions, with strong presence across the globe. As a strategic partner to some of the world’s largest healthcare organizations, CitiusTech plays a deep and meaningful role in accelerating technology innovation and shaping the way healthcare is delivered to patients.
\r\n\r\nCitiusTech works at the edge of digital transformation. It focuses on multiple areas of digital technology, such as Business Intelligence, mobility & IoT, Big Data, cloud computing, predictive analytics & data science. With cutting-edge technology expertise, world-class service quality, strong consulting expertise and a global resource base, CitiusTech consistently delivers best-in-class solutions and an unmatched cost advantage to healthcare organizations worldwide.
\r\n
Ascent Health (“Ascent”) is India’s fastest growing Pharmaceutical Commerce Platform, engaged in the entire spectrum of B2B commerce across pharmacies, practitioners, hospitals and care groups. Ascents operates as a full stack - vertically integrated platform, with in-house warehousing, distribution, supply chain and owned inventory.
\r\n\r\nWith deep investments in technology and constant innovation in the supply chain, Ascent today has a monthly revenue run rate in excess of INR 120 Crores, in less than five years of incorporation. The core B2B platform of the Ascent powers the commerce supply of pharmaceutical products – mainly formulations, to the 20,000+ pharmacies, and several thousand doctors and hospitals in Mumbai, Delhi, Gurugram, Bengaluru, Chennai, Davangere & Ahmedabad. Across the seven clusters of its operations, Ascent has achieved operational profitability and is well on its way todouble its scale in less than 15 months. Apart from pharmacies, Ascents’ platform power commerce and procurement decisions in multiple institutions such as govt. bodies and large format hospitals.
\r\n\r\nAscent has also founded and made significant investments with strategic interests in providing access to affordable healthcare to consumers /patients through digital platforms. Its interests lie in some of the largest EMR providers in India and creating a troika of platforms across patient – practitioner – pharmacy.
\r\n\r\nAscent took form in its current shape five years ago by the integration of 7 small pharmaceutical distribution units in Mumbai. By weaving a common platform enabling transparent commerce, timely supplies and assurance of 100% genuine medicines across these units, Ascent created a unique platform with compelling value. Since its launch, Ascents’ platform has seen its monthly revenue run rate more than double every 12 months, from 4 Crores in August 2014 to 120 Crores+ in August 2018, a spectacular 30x growth over the last 48 months.
\r\n\r\nWhat started as a simple platform providing access to medicines across 75 pharmaceutical companies, now provides more than 50,000 SKU’s across 500+ pharmaceutical companies through over 2,00,000 Sq. Feet of captive warehousing space, end-to-end cold chain management and a dedicated fleet of over 500 delivery partners. The platform has scaled up through a mix of organic and inorganic growth, having completed 12 acquisitions over a period of 24 months across 6 cities adding more depth to the coverage of its platform.
\r\n\r\nDriven by a dynamic founding and strong management team the Ascent is poised to create a paradigm shift in the way pharmaceutical commerce is powered in India. With platforms that provide access to 100% genuine products, transparent pricing, assured delivery timelines and access to multiple credit offerings, Ascent plans to touch 50,000+ pharmacies, 20,000+ doctors and hospitals in 12 cities over the next 18 months.
\r\n\r\nAscent is building upon its leadership in to leverage the "platform" through strategic plays such in healthcare OTC, generic drugs, brand launches, data analytics, credit guarantees, CRM programs to truly create India’s best and biggest B2B healthcare commerce entity.
\r\n
VCC Events opens up the avenues for participation. Join hands to be a part of India’s largest gathering of alternative investments leaders, industry stakeholders and Asia’s influential limited partners, general partners and marquee advisors. Your chance to actively participate and augment yourself as thought leaders.
ITC Grand Central, Mumbai
Date: Oct 9, 2018
Venue: ITC Grand Central, Mumbai
Drop us a line and we will call you.
